TY - JOUR
T1 - Adenoviral vectors expressing siRNAs for discovery and validation of gene function
AU - Arts, Gert Jan
AU - Langemeijer, Ellen
AU - Tissingh, Rudi
AU - Ma, Libin
AU - Pavliska, Heidi
AU - Dokic, Kristina
AU - Dooijes, Richele
AU - Mešić, Emir
AU - Clasen, Remko
AU - Michiels, Frits
AU - van der Schueren, Jan
AU - Lambrecht, Mark
AU - Herman, Sofie
AU - Brys, Reginald
AU - Thys, Kim
AU - Hoffman, Marcel
AU - Tomme, Peter
AU - van Es, Helmuth
PY - 2003/10/1
Y1 - 2003/10/1
N2 - RNA interference is a powerful tool for studying gene function and for drug target discovery in diverse organisms and cell types. In mammalian systems, small interfering RNAs (siRNAs), or DNA plasmids expressing these siRNAs, have been used to down-modulate gene expression. However, inefficient transfection protocols, in particular, for primary cell types, have hampered the use of these tools in disease-relevant cellular assays. To be able to use this technology for genome-wide function screening, a more robust transduction protocol, resulting in a longer duration of the knock-down effect, is required. Here, we describe the validation of adenoviral vectors that express hairpin RNAs that are further processed to siRNAs. Infection of cell lines, or primary human cells, with these viruses leads to an efficient, sequence-specific, and prolonged reduction of the corresponding target mRNA, resulting in a reduction of the encoded protein level in the cell. For knock-down of one of the targets, GαS, we have measured inhibition of ligand-dependant, G-protein-coupled signaling. It is expected that this technology will prove to be of great value in target validation and target discovery efforts.
AB - RNA interference is a powerful tool for studying gene function and for drug target discovery in diverse organisms and cell types. In mammalian systems, small interfering RNAs (siRNAs), or DNA plasmids expressing these siRNAs, have been used to down-modulate gene expression. However, inefficient transfection protocols, in particular, for primary cell types, have hampered the use of these tools in disease-relevant cellular assays. To be able to use this technology for genome-wide function screening, a more robust transduction protocol, resulting in a longer duration of the knock-down effect, is required. Here, we describe the validation of adenoviral vectors that express hairpin RNAs that are further processed to siRNAs. Infection of cell lines, or primary human cells, with these viruses leads to an efficient, sequence-specific, and prolonged reduction of the corresponding target mRNA, resulting in a reduction of the encoded protein level in the cell. For knock-down of one of the targets, GαS, we have measured inhibition of ligand-dependant, G-protein-coupled signaling. It is expected that this technology will prove to be of great value in target validation and target discovery efforts.
UR - http://www.scopus.com/inward/record.url?scp=10744221455&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=10744221455&partnerID=8YFLogxK
U2 - 10.1101/gr.1332603
DO - 10.1101/gr.1332603
M3 - Article
C2 - 12975310
AN - SCOPUS:10744221455
SN - 1088-9051
VL - 13
SP - 2325
EP - 2332
JO - Genome Research
JF - Genome Research
IS - 10
ER -